help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webb, C. B.
Right arrow Articles by Frohman, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webb, C. B.
Right arrow Articles by Frohman, L. A.

Journal of Clinical Endocrinology & Metabolism, Vol 56, 417-419, Copyright © 1983 by Endocrine Society

ARTICLES

Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenomas in vitro

CB Webb, JL Thominet and LA Frohman

The effects of an ectopic growth hormone releasing factor (E-GHRF) from a carcinoid tumor were studied in three human GH-secreting pituitary adenomas in monolayer culture. GH release by the adenomas was stimulated by 55 +/- 10%, 57 +/- 8%, and 59 +/- 17% during a 4 h exposure to E-GHRF at concentrations of 3, 0.8, and 24 Units/ml, respectively. Two of the tumors also secreted prolactin (PRL) and in one, E-GHRF (0.8 Units/ml) stimulated PRL release by 48 +/- 8%. GH and PRL release were both suppressed by somatostatin (10(-8)M) in two of the adenomas. These results 1) demonstrate for the first time E-GHRF stimulation of GH release from human pituitary tissue in vitro, 2) support an etiologic role for E-GHRF in the development of acromegaly, and 3) indicate that GH-secreting adenomas retain the capability of responding to GHRF.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
E. V. Dimaraki, W. F. Chandler, M. B. Brown, C. A. Jaffe, S. Y. Kim, R. Taussig, V. Padmanabhan, and A. L. Barkan
The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2185 - 2190.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Matsuno, H. Katakami, N. Sanno, Y. Ogino, R. Y. Osamura, S. Matsukura, N. Shimizu, and T. Nagashima
Pituitary Somatotroph Adenoma Producing Growth Hormone (GH)-Releasing Hormone (GHRH) with an Elevated Plasma GHRH Concentration: A Model Case for Autocrine and Paracrine Regulation of GH Secretion by GHRH
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3241 - 3247.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
M. Kovacs, R. D. Kineman, A. V. Schally, M. Zarandi, K. Groot, and L. A. Frohman
Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) on GH and Insulin-Like Growth Factor I Levels in Transgenic Mice Overexpressing the Human GHRH Gene, an Animal Model of Acromegaly
Endocrinology, November 1, 1997; 138(11): 4536 - 4542.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society